Moreover, OTS167 was recently reported to inhibit BUB1 and Haspin kinases as well as MELK, reducing phosphorylation at histones H2A and H3 and causing mislocalization of Aurora B, which resulted in abolishment of the mitotic checkpoint and abortion of cytokinesis in cancer cells [71]. This evidence concerns the gene MELK and cancer.